Development of Stable Nanoemulsion Formulation as an Ophthalmic Drug Delivery System for Cannabinoids

This study is aimed at developing a Nanoemulsion formulation of a poorly water-soluble and thermally, oxidatively, and photolytically unstable active pharmaceutical ingredient (API) for ophthalmic application, specifically for the reduction of intraocular pressure (IOP) and to provide neuroprotection.

Thank you for registering!

You now have the option of downloading the resource or viewing the web version below.